Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shinichi Maekawa is active.

Publication


Featured researches published by Shinichi Maekawa.


Journal of Heart and Lung Transplantation | 2009

PPARα Ligand WY14643 Reduced Acute Rejection After Rat Lung Transplantation With The Upregulation of IL-4, IL-10 and TGFβ mRNA Expression

Jun Yanagisawa; Takeshi Shiraishi; Akinori Iwasaki; Shinichi Maekawa; Takao Higuchi; Masafumi Hiratuka; Toshihiro Tanaka; Hirotomo Shibaguchi; Masahide Kuroki; Takayuki Shirakusa

BACKGROUND The peroxisome proliferators-activated receptor-alpha (PPARalpha) is important in lipid metabolism and regulation of inflammation. Recent studies have demonstrated the immunoregulatory effects of PPARalpha. This investigated the immunosuppressive effects of PPARalpha using its ligand, WY14643, on acute lung allograft rejection in a rat model and its mechanism of action. METHOD The left lungs were transplanted orthotopically from Brown-Norway donors to F344 recipients. The recipients were then divided into control and WY14643 treatment groups. The allograft rejection was evaluated by daily chest X-ray imaging and was evaluated histologically on Day 7 after transplantation. The cytokine messenger RNA (mRNA) expression at Days 3 and 5 were also evaluated in allografts and recipient spleens. RESULTS The radiologic and histologic findings indicated that treatment with the WY14643 reduced acute allograft rejection. WY14643 also significantly extended the allograft survival time. This amelioration of acute rejection by WY14643 was also associated with up-regulated interleukin (IL)-4, IL-10, and transforming growth factor-beta (TGFbeta) mRNA expression in the lung allografts and spleens. CONCLUSION This study demonstrated that the administration of the PPARa ligand, WY14643, ameliorates acute lung allograft rejection in rats. Treatment with WY14643 reduced histopathologic scores, prolonged graft survival, and up-regulated the expression of anti-inflammatory cytokine IL-4, IL-10, and TGFbeta mRNA compared with the control.


The Annals of Thoracic Surgery | 2018

Gastric Volvulus after Left Lower Lobectomy

Keita Tokuishi; Sosei Abe; Shinichi Maekawa; Toshinori Hamada; Kan Okabayashi; Keiichiro Ogoshi; Munehiro Tanaka

Gastric volvulus is a rare complication after pulmonary resection. To date, only eight cases of postpulmonary resection gastric volvulus have been reported in the English literature, and several of these patients underwent left pneumonectomy or had hiatal hernia. This report describes a case of postlobectomy gastric volvulus in a 73-year-old woman without hiatal hernia.


Anticancer Research | 2007

Sonodynamic Therapy of Cancer Using Novel Sonosensitizers

Masahide Kuroki; Ken Hachimine; Hironori Abe; Hirotomo Shibaguchi; Motomu Kuroki; Shinichi Maekawa; Jun Yanagisawa; Tetsushi Kinugasa; Toshihiro Tanaka; Yuichi Yamashita


Anticancer Research | 2007

Selective Up-regulation of Claudin-1 and Claudin-2 in Colorectal Cancer

Tetsushi Kinugasa; Qun Huo; Daijiro Higashi; Hirotomo Shibaguchi; Motomu Kuroki; Toshihiro Tanaka; Kitarou Futami; Yuichi Yamashita; Ken Hachimine; Shinichi Maekawa; Kazuki Nabeshima; Hiroshi Iwasaki; Masahide Kuroki


Anticancer Research | 2007

Correlation Between Lymph Node Metastasis and the Expression of VEGF-C, VEGF-D and VEGFR-3 in T1 Lung Adenocarcinoma

Shinichi Maekawa; Akinori Iwasaki; Takayuki Shirakusa; Sotaro Enatsu; Takehito Kawakami; Motomu Kuroki; Masahide Kuroki


Oncology Reports | 2008

Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma.

Shinichi Maekawa; Akinori Iwasaki; Takayuki Shirakusa; Takehito Kawakami; Jun Yanagisawa; Toshihiro Tanaka; Hirotomo Shibaguchi; Testushi Kinugasa; Motomu Kuroki; Masahide Kuroki


Anticancer Research | 2006

Possible Applications of Antibodies or their Genes in Cancer Therapy

Masahide Kuroki; Jian Huang; Hirotomo Shibaguchi; Toshihiro Tanaka; Jun Zhao; Naixiang Luo; Ken Hachimine; Tetsushi Kinugasa; Shinichi Maekawa; Sotaro Enatsu; Wakako Hamanaka; Tatsuya Fukami; Motomu Kuroki


Thoracic and Cardiovascular Surgeon | 2005

Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD).

Akinori Iwasaki; Takayuki Shirakusa; Sotarou Enatsu; Shinichi Maekawa; Y. Yoshida; Yasuteru Yoshinaga


Thoracic and Cardiovascular Surgeon | 2006

Prognostic Significance of Subcarinal Station in Non-Small Cell Lung Cancer with T1 - 3 N2 Disease

Akinori Iwasaki; Takayuki Shirakusa; Tatsu Miyoshi; Hamada T; Sotarou Enatsu; Shinichi Maekawa; Hiratsuka M


Interactive Cardiovascular and Thoracic Surgery | 2005

Is T2 non-small cell lung cancer located in left lower lobe appropriate to upstage?

Akinori Iwasaki; Takayuki Shirakusa; Sotarou Enatsu; Shinichi Maekawa; Yasuteru Yoshinaga; Satoshi Yoneda; Seiichiro Hoshino

Collaboration


Dive into the Shinichi Maekawa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kan Okabayashi

University of Occupational and Environmental Health Japan

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge